Skip to main content
PLOS One logoLink to PLOS One
. 2025 Mar 11;20(3):e0319661. doi: 10.1371/journal.pone.0319661

Is it all in your head? Reducing virtual reality induced cybersickness by pleasant odor imagery

Luca Fantin 1,2,3, Gabriela Hossu 1,4, Cécile Rumeau 5,6, Guillaume Drouot 4, Hadrien Ceyte 2,*
Editor: Jeyasakthy Saniasiaya7
PMCID: PMC11896048  PMID: 40067876

Abstract

Although immersive technologies such as virtual reality are constantly growing for personal and professional purposes, their use can often induce a transient state of discomfort known as cybersickness, resulting in numerous symptoms and perceptive-motor vulnerability. In an attempt to develop leads to mitigate cybersickness, encouraging findings have reported decreased symptoms during the presentation of pleasant smells. However, the diffusion of smells in ecological settings is very challenging. An interesting alternative could reside in odor imagery (OI), known for its neurophysiological, behavioral and psychological similarities with odor perception. The aim of this study was therefore to determine the effects of pleasant OI on virtual reality induced cybersickness. Thirty participants performed two 14-minute virtual reality sessions simulating a first-person view from a boat. During the second session we added a picture at the center of the visual field, allowing for pleasant and intense OI based on individualized psychometrical measures. Participants were instructed to focus on the smell evoked by this picture. For both immersions, cybersickness was characterized by the evolution of scores on the Simulator Sickness Questionnaire, and duration of immersion. Our results show that both measures were positively affected by pleasant OI, indicating a decreased intensity of cybersickness symptoms associated with a longer tolerance of the virtual environment. We suggest the observed effects could be mediated by emotional regulation mechanisms driven by pleasant OI, alleviating cybersickness in a similar way to pleasant odor perception. These findings could open the door to new applications of pleasant sensory imagery as strategies to alleviate transient states of discomfort in immersive technologies or perhaps motion-induced sickness.

Introduction

The use of immersive virtual technologies, and particularly virtual reality (VR) has astoundingly grown over the past decade. While VR is mostly used for leisure, it is becoming essential in the fields of industry [1], or for pedagogical purposes in surgeons [2] or pilots [3]. In the field of research, VR can also be of great interest since it offers controlled environmental conditions, and can negate visual distractors. It is therefore used to study cognitive-motor behaviors in controlled visual environments with limited logistical constraints. However, the use of VR can quite often lead to a state of discomfort known as cybersickness. Usually defined as the result of a cognitive-sensory conflict [4], cybersickness can manifest through several symptoms categorized in nausea, oculomotor symptoms, and disorientation [5,6]. Furthermore, recent findings have shown that cybersickness induces an alteration of the importance attributed to visual cues in geocentric perception, which could induce posture-locomotor vulnerability in some at-risk populations [7]. Although numbers vary, it has been reported that in some cases up to 80% can be subject to this state of discomfort in VR [810]. Given the place of VR nowadays and the consistently increasing number of users, it has become a public health issue to determine the factors capable of reducing the risk of cybersickness. In this regard, the occurrence of cybersickness can admittedly be modulated by multiple factors related to hardware, the cognitive load of the task performed in VR [11], the virtual environment itself or characteristics related to the user. To this day however, most work has focused on the latter (i.e., human factors). For example, higher intensity of cybersickness has been shown in women [12] and individuals with higher static field dependence [7] or sensitivity to visual cues broadly speaking [13]. On the other hand, greater experience with video games has been associated with decreased cybersickness [14]. Overall, these human factors are difficult or impossible to control, although they may help with setting recommendations. An alternative which may prove more efficient in preventing cybersickness on short notice resides in environmental factors. To this day only little is known about how controlling the environment can help alleviate cybersickness, and more generally speaking all forms of visually-induced states of discomfort. In one notable study [15], it was shown that the diffusion of a pleasant odor (smell of rose) during a first-person cycling simulation, significantly reduced the intensity of symptoms. The interpretation of these results is that the pleasant odor elicited a positive emotional state in participants, reorienting their attention towards these emotions rather than the nauseogenic attribute of the visual stimulation [16]. Although this finding was a significant advance, the diffusion of smells in ecological situations can be limited by several factors, such as the cost and technicity of the material used for odor diffusion, or psychophysical issues related to subjectivity of odor pleasantness and intensity [17].

In this study we propose to study another form of olfaction, namely odor imagery (OI), which can be described as the mental simulation of a smell in absence of the corresponding physical stimulation [18,19]. Though its existence has been questioned in the past, the ability to generate odor images is now commonly accepted and can be facilitated by the presence of complementary sensory information such as visual cues, especially those providing more semantical context (i.e., pictures and words) [20]. Across the years, numerous neurophysiological, psychological and behavioral similarities between odor perception and OI have been demonstrated [2124]. In particular, odor perception and OI seem to share neural pathways, both involving brain regions with a role in emotional regulation [2527]. Moreover, activity in brain regions such as the insula which has strong limbic connections, can be modulated by hedonicity of both perceived smells and mental odor images [28]. Therefore, if cybersickness can be alleviated by emotional states mediated by olfaction, performing pleasant OI during VR immersion may provide similar effects while being free of the technical and material limits of odor diffusion. The aim of the present study was thus to determine the impact of pleasant OI on VR-induced cybersickness, expressed by the intensity of symptoms and the duration of VR immersion.

Materials and methods

This study received ethical approval by the local ethics committee (“CANOE” clinical trial; ClinicalTrials.gov Identifier: NCT05308433). The recruitment period began on April 14th, 2022 and ended on July 12th, 2022. Thirty healthy volunteers (14 women, 16 men; mean age =  22.5 years old; SD =  3.4) took part in this study. Oral and written informed consents were obtained from each participant before inclusion. Non-inclusion criteria related to this part of the clinical trial were any olfactory disorder or non-corrected visual impairment. All participants were characterized as being sufficiently able to imagine smells by obtaining a score strictly below 2.5/5 on the French Vividness of Olfactory Imagery Questionnaire (fVOIQ) [29]. This study consisted of 2 experimental visits organized at least 6 months apart.

Preliminary questionnaires

At the beginning of visit 1, participants completed the short Motion Sickness Susceptibility Questionnaire (MSSQ-short) [30], the short version of the Visually Induced Motion Sickness Susceptibility Questionnaire (VIMSSQ-short) [31], and the Immersive Tendencies Questionnaire (ITQ) [32] in their French versions. These questionnaires were used in order to characterize past experiences with immersive technologies, and situations of transient discomfort.

Ratings of visually evoked odor images

After completing the preliminary questionnaires at the start of visit 1, participants were asked to rate mentally simulated odor images. Seven pictures representing rose, violet, lavender, cucumber, strawberry, orange blossom and peppermint [20] were successively presented, and participants were instructed to concentrate on the odor evoked by each of these pictures. If they managed to generate a mental odor image, participants indicated the pleasantness and the intensity of this odor image on scales ranging from 1 to 4 (a high score indicating more pleasant/intense OI). Otherwise, they were instructed not to provide a rating. These data were collected in order to set individualized visual conditions during the VR immersion of visit 2 (see in the following section).

Virtual immersions

During both visits, all participants performed a VR immersion in a simulated first-person view from a boat as described by Fantin et al. [7], equipped with an HTC Vive Pre (HTC, Taouyuan, Taïwan) head-mounted display. This virtual environment has been designed and previously used specifically to induce discomfort in experimental settings. Amplitude and frequencies of waves and simulated movements of the head in 3 dimensions make the environment visually unpredictable, facilitating the occurrence of a sufficient but tolerable level of cybersickness in more sensitive participants. The parameters used in this study are described in Fantin et al.’s original publication. Before each immersion, participants were asked to verbalize their current state of discomfort using the Fast Motion Sickness Scale (FMS) [33], ranging from 0 (absolutely no discomfort) to 20 (extreme discomfort). If a score strictly below 2/20 was verbalized, participants were instructed to complete the Simulator Sickness Questionnaire (SSQ) [6], which provided us with baseline information regarding their state before immersion. Then, the VR immersions could begin. Each immersion lasted a maximum of 14 minutes. Every minute, participants were asked to verbalize their state of discomfort using the FMS scale. If the verbalized score reached 16/20 or over, or if participants expressed the will to stop, the immersions were discontinued.

Although the virtual environment used for both visits was identical, some visual information present in the visual field was manipulated. During visit 1 (Fig 1A), a black square frame (size =  17 degrees of the visual field) was placed at the center of the visual field and locked in order to stay centered despite any head movements. This frame was added to give participants static visual information on orientations, in order to control for the visual conditions of visit 2. Participants were informed they were allowed to place their gaze where they preferred but were also advised not to move their head in an unreasonable manner. During visit 2 (Fig 1 B), a picture among the 7 pictures rated during visit 1 was added to the center of the field of view (size =  17 degrees). The content of the picture was individually selected as having evoked the most pleasant and intense mental odor image during visit 1. The specific instruction given to participants for this visit was to concentrate on the odor evoked by the picture. It was specified that they were free not to look at the picture at all times, but that the picture was there to help them evoke the odor for as long as possible.

Fig 1. Virtual environment used for the VR immersions.

Fig 1

A) visual setting of the control immersion (visit 1); B) associated to an OI task (visit 2, example of a picture representing strawberry).

Directly after virtual removing the head-mounted display, participants completed the SSQ a second time, in order to assess the intensity of post-immersion cybersickness symptoms. The French version of the Igroup Presence Questionnaire (IPQ) [34] was also completed.

Assessment of static field dependence

During both visits, static field dependence was assessed using the Rod and Frame Test (RFT). Participants were seated, equipped with the VR head-mounted display, and their head was held upright by a chinrest. In the VR headset, a 40 deg-tilted red rod was placed in an 18 deg-tilted gray frame. Using a videogame console controller, participants were instructed to rotate the rod until they judged it vertical (i.e., aligned with gravity). Eight trials were organized in 2 blocks of 4, corresponding to the 2 tilt directions of the frame (left or right). The direction of the initial tilt of the rod (left or right) was counterbalanced between blocks. There was no time limit, but participants were encouraged to answer spontaneously in a reasonable time frame. The RFT was performed before and after both virtual immersions. A representation of the time course of each visit is depicted in Fig 2.

Fig 2. Time course of both experimental visits.

Fig 2

A and B represent visits 1 and 2 respectively.

Data processing and statistical analysis

All data was stored in a pseudonymized database. For each visit, we considered and processed three indicators of user experience: SSQ scores, immersion duration, and sense of presence. Ratings for each completed SSQ were converted into a global score as described by Kennedy et al. [6]. For both visits, a SSQpre and a SSQpost score were obtained from the pre and post-immersion total scores on the SSQ respectively. Then, SSQevol scores were calculated for each visit by subtracting SSQpre to SSQpost scores. A higher SSQevol score indicates a broader effect of the virtual immersion on the self-declared intensity of cybersickness symptoms. Immersion duration corresponded to the number of minutes entirely performed in the virtual environment. Sense of presence scores corresponded to the IPQ global scores as described by Schubert et al. [34], higher scores indicating stronger sense of presence.

Scores obtained from the RFT were also processed for both visits. For each trial, we considered the angular difference between the objective vertical (i.e., direction of gravity) and the estimated vertical. Errors performed in the direction of tilt of the frame were noted positive, and errors in the opposite direction were noted as negative. Therefore, each participant obtained a RFTpre and RFTpost score for each visit, calculated by averaging the 8 errors on pre and post-immersion trials respectively. For both visits, a RFTevol score was obtained for each participant and each trial by subtracting RFTpre scores from RFTpost scores.

Our statistical analysis first sought to investigate the effect of pleasant OI on cybersickness. To this end, we compared SSQevol scores, immersion duration in minutes and IPQ scores between visits using statistical tests for paired samples.

Then, a linear mixed effects model was performed in order to determine which human or experimental factors contributed the most toward explaining SSQevol scores. Because of our intrasubject experimental design, we entered participants as a random effect. Thus, the following model was constructed:

SSQevol=Visit+Gender+SSQpre+Visit:SSQpre+RFTpre+Visit:RFTpre+IPQ+RFTevol+(1|Participant)

We included Visit:SSQpre and Visit:RFTpre interactions as fixed effects in order to account for any potential differences in initial states of our participants between visits, which were planned 6 months apart. Numerical data used in this model were reduced centered (converted to z-scores). Removal of one influential observation was performed after plotting standardized residuals against leverage. Collinearity, residual homoscedasticity, and residual linearity were verified. Although residuals presented heteroscedasticity, data were not further transformed given the little effect of this type of assumption violation on estimate bias in mixed effects models [35].

All statistical analyses were performed using Rstudio (version 2023.12.1) running on R (version 4.3.2). The mixed effects linear model was performed using the lmer function of the lme4 package [36]. Assumptions were verified using the performance package. Detailed results of the mixed effects model were obtained using the sjPlot package [37] (predictor estimates, confidence intervals and p-values as well as random effects) and performance package [38] (global performance of the model). The nature of statistical analyses for paired comparisons for the effect of session was defined after verifying normality of data using Shapiro-Wilk tests. The threshold for significance was set by default to 0.05. Quantitative data were therefore expressed either as means associated to standard deviation (SD), or medians (Med) associated to interquartile range (IQR). Qualitative data were expressed by their frequencies. All data used for the descriptive statistics or formal analyses are publicly available at https://doi.org/10.6084/m9.figshare.26927116.v1

Results

Two participants did not perform the second visit since they declared having suffered from a smell-affecting illness (namely Covid) between visits, their data was therefore discarded. The descriptive data of the remaining 28 participants are available in Table 1.

Table 1. Descriptive data of the population before the control VR immersion.

Characteristics N =  28
Gender
 Male 15 [53.6%]
 Female 13 [46.4%]
Age 23 (4) |  19–33
fVOIQ 1.94 (0.35) |  1.31–2.44
MSSQ-short 15 (10) |  0–34
VIMSSQ-short 6 (3) |  0–12
ITQ 93 (13) |  68–114
RFTpre (Visit 1) 4.80 (3.12) |  0.90–13.95
N [%]; Mean (SD) |  Min–Max

Signed ranks Wilcoxon tests were performed to assess the effect of visit on SSQevol scores, duration immersion and IPQ scores (Fig 3). Our results show that for SSQevol scores, participants presenting were significantly lower scores after the visit with OI (Med =  9.35; IQR =  33.7) compared to the control visit (Med =  35.5; IQR =  74.8; p =  0.038; effect size =  0.37). Moreover, immersion durations were significantly higher during OI (Med =  14; IQR =  0) than during the control visit (Med =  14; IQR =  7.25; p =  0.002; effect size =  0.65). Finally, our analysis did not reveal any significant effect of visit on IPQ scores.

Fig 3. Boxplot representations of user experience variables as a function of visit.

Fig 3

Pairwise comparisons were performed on A) SSQevol scores, B) immersion durations and C) IPQ scores (*: p <  0.05; **: p <  0.01). Medians and quartiles are represented, points and lines indicate individual values.

The mixed effects model used to explain SSQevol scores revealed that only the effect of visit was statistically significant (p =  0.01). The Akaike Information Criterion (AIC) of the model was 504.42. Details on the model are provided in Table 2

Table 2. Detailed values of predictors and random effects for the linear mixed effects model explaining SSQevol scores.

Predictors Beta 95% confidence interval p
Constant 44.26 [21.22; 67.30]  <0.001
Visit [2]a −20.88 [−38.24; −3.52] 0.02
Gender [Men] −2.64 [−32.21; 26.93] 0.86
SSQpre −2.09 [−15.08; 10.90] 0.75
Visit [2] *  SSQpre −4.96 [−23.87; 13.96] 0.60
RFTpre −17.81 [−36.10 ;0.48] 0.06
Visit [2] *  RFTpre 9.86 [−7.35 ;27.08] 0.25
IPQ 7.46 [−4.58; 19.49] 0.22
RFTevol −7.34 [−17.32; 2.63] 0.15
Random effects
σ2 746.51
τ00 Participant 924.67
ICC 0.55
Marginal R2 0.14
Conditional R2 0.62

aVisit [2] =  Visit including OI during virtual immersion

Discussion

This study proposed an innovative environmental-based solution for alleviating cybersickness in VR, using pleasant visuo-olfactory evocation. Our results corroborate those observed in the case of pleasant odor perception [15], as we show a decrease SSQevol scores, associated to an increased immersion duration. In other words, not only did participants experience less intense cybersickness symptoms when generating pleasant odor images, but they also tolerated the virtual environment for a longer period. The lower SSQevol scores observed during this second visit therefore cannot be attributed to premature exit from the virtual stimulation. Moreover, although the observed effects are subject to residual interindividual variability certainly due to other factors which were not measured, our mixed effects model showed that the effect of session was the most explanatory of the SSQevol scores, and our only statistically significant fixed effect. Thus, pleasant OI seems to be a method allowing for alleviation of cybersickness in more sensitive users, while not negatively affecting user experience in those less prone to discomfort.

Given the numerous similarities reported between odor perception and OI, it is possible that the mechanisms explaining the alleviation of cybersickness in both cases are comparable, that is to say mediated by emotional processes [16]. Indeed, the reported involvement of brain regions during OI such as the insula and the DLPFC [2527] do suggest that many processes related to emotional regulation take place when this task is successfully performed. Therefore, we can suppose that pleasant OI elicited specific emotional states leading to a decrease in cybersickness, although the mechanisms underpinning this effect are still not certain. The interpretation proposed in the case of odor diffusion [15,16] is anchored in the modal model of emotional regulation [39] consisting in the succession of situation, attention, appraisal, and response. According to this model, appraisal is understood as the meaning given to the situation by an individual, which then manifests as “a coordinated yet malleable multisystem response” in the context of the situation [40]. The decrease in cybersickness would therefore be one tangible consequence of this multisystem response taking place at a physiological level, although this remains to be demonstrated using more direct measures. For instance, it would be relevant investigate biological indicators such as those obtained from heart rate variability, in the light of the well-known interactions between the brain and heart occurring in situations of emotional regulation [41]. One other arising question is whether such emotional states can be obtained from imagery in other sensory modalities. It has indeed been thoroughly discussed that OI is particularly difficult compared to sensory imagery in other modalities [19,42,43]. Therefore, while our results are very encouraging and open new perspectives for the alleviation of cybersickness based on sensory imagery, one potential limitation of this approach could be related to the necessary cognitive load, in particular when performing a task simultaneously. However, if multisystem responses as described in the modal model can be obtained from emotional states regardless of how they are inducted, perhaps pleasant using visual or auditory imagery could prove more efficient. Because these are known to be easier to perform and concern a greater proportion of the population, such an approach could help reduce cognitive load and improve the applicability of such a strategy in ecological settings. Further studies should therefore seek to determine whether the outcomes of our study are specific to olfaction or are transposable to other sensory modalities.

It is nevertheless possible that other factors may have contributed to the effects observed in our work. For example, it is known that adding a visual anchorage in virtual environments can contribute to decreasing symptoms of cybersickness by reducing the amount of visual flux users are exposed to. Perhaps in our study, the pictures used during the second VR immersion acted as an anchorage. In the control visit, we attempted to control for this by adding a still frame in the center of the visual field. While this method does provide static visual information about verticality and horizontality, we cannot assert that it has identical effects to pictures since visual flux was present inside the frame contrarily to pictures which were opaque. However, IPQ scores did not indicate any significant increase or decrease in sense of presence between visits, suggesting no effect of placing a picture in the visual field. Secondly, one could wonder whether the effect of OI is simply driven by reallocating participants’ attention towards the OI task rather than the virtual world, regardless of the user’s subsequent emotional state. In this case, pleasant and unpleasant OI would have similar effects on cybersickness. In order to investigate these two alternative interpretations (visual flux and attention reallocation), we are currently carrying out a complementary study using different conditions of visual anchorage and OI hedonicity. Preliminary results on 19 participants (not shown here) suggest a decrease in cybersickness compared to a control condition, only when OI is rated as pleasant. Although it remains to be confirmed, it seems that our preliminary results are therefore in favor of the hypothesis of emotional regulation, which remains to be confirmed by measures of autonomic activity. If so, these first findings may open the door to novel approaches for the mitigation of transient states of discomfort using induction of emotional states, not only in the context of immersive technologies but perhaps also in other settings such as motion sickness in means of transportation.

Conclusion

The present study aimed at determining the effect of pleasant OI on VR-induced cybersickness. Our main results show a decrease in the intensity of cybersickness symptoms when participants performed OI, associated with a longer tolerance of the virtual environment. These encouraging findings suggest the potential relevance of self-induced emotional states to improve well-being during virtual immersions. One remaining issue which should motivate future work resides in the cognitive load necessary for OI, possibly negatively affecting users’ performance at primary tasks that require active involvement (e.g., navigation or physical interactions). If OI reveals itself too problematic, our results still open the door toward the use of other forms of sensory imagery or less costly cognitive mechanisms to alleviate transient states of discomfort, whether they are in virtual environments or not.

Data Availability

All data used for the descriptive statistics or formal analyses are publicly available at https://doi.org/10.6084/m9.figshare.26927116.v1

Funding Statement

This work is co-funded by the French State-Region contract CPER 2015-2020 (Contrat de Plan Etat Région– IT2MP Innovations Technologiques, Modélisation et Médecine Personnalisée), by the European Union through the European Regional Development Fund “FEDER-FSE Lorraine et Massif des Vosges 2014-2020” and by the CHRU of Nancy, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Turner CJ, Hutabarat W, Oyekan J, Tiwari A. Discrete event simulation and virtual reality use in industry: new opportunities and future trends. IEEE Trans Human-Mach Syst. 2016;46(6):882–94. doi: 10.1109/thms.2016.2596099 [DOI] [Google Scholar]
  • 2.Bric JD, Lumbard DC, Frelich MJ, Gould JC. Current state of virtual reality simulation in robotic surgery training: a review. Surg Endosc. 2016;30(6):2169–78. doi: 10.1007/s00464-015-4517-y [DOI] [PubMed] [Google Scholar]
  • 3.Dymora P, Kowal B, Mazurek M, Romana S. The effects of virtual reality technology application in the aircraft pilot training process. IOP Conf Ser: Mater Sci Eng. 2021;1024(1):012099. doi: 10.1088/1757-899x/1024/1/012099 [DOI] [Google Scholar]
  • 4.Rebenitsch L, Owen C. Review on cybersickness in applications and visual displays. Virtual Reality. 2016;20(2):101–25. doi: 10.1007/s10055-016-0285-9 [DOI] [Google Scholar]
  • 5.Bijveld M, Bronstein A, Golding J, Gresty M. Nauseogenicity of off-vertical axis rotation vs. equivalent visual motion. Aviation Space Environ Med. 2008;79(7):661–5. doi: 10.3357/asem.2241.2008 [DOI] [PubMed] [Google Scholar]
  • 6.Kennedy R, Lane N, Berbaum K, Lilienthal M. Simulator sickness questionnaire: an enhanced method for quantifying simulator sickness. Int J Aviat Psychol. 1993;3(3):203–20. [Google Scholar]
  • 7.Fantin L, Ceyte G, Maïni E, Hossu G, Ceyte H. Do individual constraints induce flexibility of visual field dependence following a virtual immersion? Effects of perceptive style and cybersickness. Virtual Reality. 2022;27(2):917–28. doi: 10.1007/s10055-022-00703-w [DOI] [Google Scholar]
  • 8.LaViola JJ Jr. A discussion of cybersickness in virtual environments. SIGCHI Bull. 2000;32(1):47–56. doi: 10.1145/333329.333344 [DOI] [Google Scholar]
  • 9.Stoffregen TA. Cybersickness and Postural Instability, and Cybersickness: Causes and Solutions. Los Angeles: SIGGRAPH; 2019. [Google Scholar]
  • 10.Kim YY, Kim HJ, Kim EN, Ko HD, Kim HT. Characteristic changes in the physiological components of cybersickness. Psychophysiology. 2005;42(5):616–25. doi: 10.1111/j.1469-8986.2005.00349.x [DOI] [PubMed] [Google Scholar]
  • 11.Jasper A, Sepich N, Gilbert S, Kelly J, Dorneich M. Predicting cybersickness using individual and task characteristics. Comput Hum Behav. 2023 Sep;146:107800. doi: 10.1016/j.chb.2023.107800 [DOI] [Google Scholar]
  • 12.Stanney K, Fidopiastis C, Foster L. Virtual reality is sexist: but it does not have to be. Front Robot AI. 2020 Jan 31;7:4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fulvio J, Ji M, Rokers B. Variations in visual sensitivity predict motion sickness in virtual reality. Entertainment Comput. 2021 Feb;38:100423. [Google Scholar]
  • 14.De Leo G, Diggs LA, Radici E, Mastaglio TW. Measuring sense of presence and user characteristics to predict effective training in an online simulated virtual environment. Simul Healthc. 2014 Feb;9(1):1–6. doi: 10.1097/SIH.0b013e3182a99dd9 [DOI] [PubMed] [Google Scholar]
  • 15.Keshavarz B, Stelzmann D, Paillard A, Hecht H. Visually induced motion sickness can be alleviated by pleasant odors. Exp Brain Res. 2015 May;233(5):1353–64. doi: 10.1007/s00221-015-4209-9 [DOI] [PubMed] [Google Scholar]
  • 16.Li CA, Yeh SL. What you smell affects different components of your visual attention. i-Perception. 2011 Oct;2(8):942–942. [Google Scholar]
  • 17.Teixeira M, Rodríguez O, Mata V, Rodrigues A. The diffusion of perfume mixtures and the odor performance. Chem Eng Sci. 2009 Jun;64(11):2570–89. [Google Scholar]
  • 18.Andrade J, May J, Kavanagh D. Sensory imagery in craving: From cognitive psychology to new treatments for addiction. J Exp Psychopathol. 2012 Apr;3(2):127–45. [Google Scholar]
  • 19.Stevenson RJ, Case TI. Olfactory imagery: a review. Psychon Bull Rev. 2005 Apr;12(2):244–64. doi: 10.3758/bf03196369 [DOI] [PubMed] [Google Scholar]
  • 20.Fantin L, Ceyte H, Rumeau C, Drouot G, Hossu G. Semantical visual information facilitates odor imagery: a combined neurophysiological and psychological approach. doi: 10.22541/au.172114326.62330224/v1 2024. [cited 03 August 2024]. Available from: https://advance.sagepub.com/doi/full/10.22541/au.172114326.62330224/v1 [DOI] [Google Scholar]
  • 21.Bensafi M, Porter J, Pouliot S, Mainland J, Johnson B, Zelano C, et al. Olfactomotor activity during imagery mimics that during perception. Nat Neurosci. 2003 Nov;6(11):1142–4. doi: 10.1038/nn1145 [DOI] [PubMed] [Google Scholar]
  • 22.Bensafi M, Pouliot S, Sobel N. Odorant-specific patterns of sniffing during imagery distinguish ‘bad’ and ‘good’ olfactory imagers. Chemical Senses. 2005 Jul;30(6):521–9. [DOI] [PubMed] [Google Scholar]
  • 23.Carrasco M, Ridout JB. Olfactory perception and olfactory imagery: a multidimensional analysis. J Exp Psychol Hum Percept Perform. 1993;19(2):287–301. doi: 10.1037//0096-1523.19.2.287 [DOI] [PubMed] [Google Scholar]
  • 24.Plailly J, Delon-Martin C, Royet J-P. Experience induces functional reorganization in brain regions involved in odor imagery in perfumers. Hum Brain Mapp. 2012 Jan;33(1):224–34. doi: 10.1002/hbm.21207 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Djordjevic J, Zatorre RJ, Petrides M, Boyle JA, Jones-Gotman M. Functional neuroimaging of odor imagery. Neuroimage. 2005;24(3):791–801. doi: 10.1016/j.neuroimage.2004.09.035 [DOI] [PubMed] [Google Scholar]
  • 26.Flohr ELR, Arshamian A, Wieser MJ, Hummel C, Larsson M, Mühlberger A, et al. The fate of the inner nose: odor imagery in patients with olfactory loss. Neuroscience. 2014 May;268:118–27. doi: 10.1016/j.neuroscience.2014.03.018 [DOI] [PubMed] [Google Scholar]
  • 27.Hossu G, Fantin L, Charroud C, Felblinger J, Jacquot M, Ceyte H. Neural mechanisms of odour imagery induced by non-figurative visual cues. Neuropsychologia. 2024 Apr;196:108836. doi: 10.1016/j.neuropsychologia.2024.108836 [DOI] [PubMed] [Google Scholar]
  • 28.Bensafi M, Sobel N, Khan RM. Hedonic-specific activity in piriform cortex during odor imagery mimics that during odor perception. J Neurophysiol. 2007;98(6):3254–62. doi: 10.1152/jn.00349.2007 [DOI] [PubMed] [Google Scholar]
  • 29.Fantin L, Ceyte H, Ramdane-Cherif Z, Jacquot M, Hossu G. French vividness of olfactory imagery questionnaire: a potential tool for diagnosing olfactory loss by assessing olfactory imagery? Front Psychol. 2020 Dec 21;11:606667. doi: 10.3389/fpsyg.2020.606667 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Golding J. Predicting individual differences in motion sickness susceptibility by questionnaire. Personality Individual Differences. 2006 Jul;41(2):237–48. [Google Scholar]
  • 31.Golding J, Rafiq A, Keshavarz B. Predicting individual susceptibility to visually induced motion sickness by questionnaire. Front Virtual Reality. 2021 Feb 26;2:576871. [Google Scholar]
  • 32.Witmer BG, Singer MJ. Measuring presence in virtual environments: a presence questionnaire. Presence. 1998 Jun;7(3):225–40. doi: 10.1162/105474698565686 [DOI] [Google Scholar]
  • 33.Keshavarz B, Hecht H. Validating an efficient method to quantify motion sickness. Hum Factors. 2011 Aug;53(4):415–26. doi: 10.1177/0018720811403736 [DOI] [PubMed] [Google Scholar]
  • 34.Schubert T, Friedmann F, Regenbrecht H. The experience of presence: factor analytic insights. Presence: Teleoperators Virtual Environ. 2001 Jun;10(3):266–81. doi: 10.1162/105474601300343603 [DOI] [Google Scholar]
  • 35.Schielzeth H, Dingemanse NJ, Nakagawa S, Westneat DF, Allegue H, Teplitsky C, et al. Robustness of linear mixed‐effects models to violations of distributional assumptions. Methods Ecol Evol. 2020 Sep;11(9):1141–52. doi: 10.1111/2041-210x.13434 [DOI] [Google Scholar]
  • 36.Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4; 2014. [Google Scholar]
  • 37.Lüdecke MD. package “sjPlot” [Internet]. 2024. Available from: https://strengejacke.github.io/sjPlot/. [Google Scholar]
  • 38.Lüdecke D, Ben-Shachar M, Patil I, Waggoner P, Makowski D. performance: An R package for assessment, comparison and testing of statistical models. JOSS. 2021 Apr 21;6(60):3139. doi: 10.21105/joss.03139 [DOI] [Google Scholar]
  • 39.Gross JJ, Ford BQ, editors. Handbook of emotion regulation. Third edition. New York, NY: The Guilford Press; 2024. [Google Scholar]
  • 40.Gross JJ. Emotion regulation. In: Handbook of emotions. New York: The Guilford Press; 2008. p. 497–513. [Google Scholar]
  • 41.Park G, Thayer JF. From the heart to the mind: cardiac vagal tone modulates top-down and bottom-up visual perception and attention to emotional stimuli. Front Psychol. 2014;5:278. doi: 10.3389/fpsyg.2014.00278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Schifferstein HNJ. Comparing mental imagery across the sensory modalities. Imagination Cognition Personality. 2009 Jun;28(4):371–88. [Google Scholar]
  • 43.White K, Ashton R, Law H. The measurement of imagery vividness: effects of format and order on the Betts’ questionnaire upon mental imagery. Can J Behav Sci. 1978.;10(1):68–78. [Google Scholar]

Decision Letter 0

Jeyasakthy Saniasiaya

21 Oct 2024

PONE-D-24-38671Is it all in your head? Reducing virtual reality induced cybersickness by pleasant odor imageryPLOS ONE

Dear Dr. Ceyte,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Justify the research question

Please submit your revised manuscript by Dec 05 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Jeyasakthy Saniasiaya, MD, MMed ORLHNS, FEBORLHNS

Academic Editor

PLOS ONE

Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following financial disclosure: "This work is co-funded by the French State-Region contract CPER 2015-2020 (Contrat de Plan Etat Région– IT2MP Innovations Technologiques, Modélisation et Médecine Personnalisée), by the European Union through the European Regional Development Fund “FEDER-FSE Lorraine et Massif des Vosges 2014-2020” and by the CHRU of Nancy, France."  Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This work is co-funded by the French State-Region contract CPER 2015-2020 (Contrat de Plan Etat Région– IT2MP Innovations Technologiques, Modélisation et Médecine Personnalisée), by the European Union through the European Regional Development Fund “FEDER-FSE Lorraine et Massif des Vosges 2014-2020” and by the CHRU of Nancy, France." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "This work is co-funded by the French State-Region contract CPER 2015-2020 (Contrat de Plan Etat Région– IT2MP Innovations Technologiques, Modélisation et Médecine Personnalisée), by the European Union through the European Regional Development Fund “FEDER-FSE Lorraine et Massif des Vosges 2014-2020” and by the CHRU of Nancy, France." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement. 

Additional Editor Comments:

Justify how this study adds to the current knowledge

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting study investigating the effects of odor imagery on cybersickness. Using a within-subject design, the authors examined whether individuals (N = 28) demonstrate changes in cybersickness across two timepoints (with 6 months apart), having watched images of pleasant fruit (different for each subject) at T2. The results indicate that cybersickness was significantly lower during the 2nd visit, where odor imagery was displayed during the VR task (as opposed to a black square during the VR task for the 1st visit). The study is concise, largely well-written, and focuses on an interesting topic. There are some caveats, however, detailed below.

• The authors should provide a clear justification for the use of within- rather than a between-subjects design. The reason for this is that it is not possible to deduce that the reduction in cybersickness was due to odor imagery, as there should have been a comparison or a control group not receiving the OI.

• In addition, a priori power analysis should have been conducted and reported, but if this was not done, then sensitivity analysis would be useful considering the small sample. Having run a quick power analysis using similar parameters, the current sample size appears to be too small (my results yielded a minimum sample of 36). The authors should expand on this.

• The authors should justify the use of their VR immersion scenario. It sounds like the scenario was designed to induce cybersickness (in addition, the authors should provide more details about this, rather than just a reference), and that participants were asked to sit still and not tilt their head too much Nevertheless, cybersickness often appears in more innocuous scenarios (e.g., walking around, peering down, etc.). How does the study scenario compare to cybersickness induced by more typical usage (e.g., during video game play)? This should be clarified.

• Methods: there are details lacking about psychometric properties of the scales used, the type of standardization method used for numerical data, and how outlier removal was conducted (and why it was removed rather than using other methods, considering the small sample size).

• A major limitation regarding the study conclusions is the effect of familiarity using the VR the 2nd time around. Although the participants were asked about their motion sickness susceptibility and prior engagement with technology, having experienced the VR scenario once does create familiarity with the environment the next time around, which could impact on cybersickness (see e.g., Petri et al., 2020).

• On a minor note, I suggest the paper is proof-read by an English speaker, as there are minor grammatical errors throughout (e.g., Introduction, 1st paragraph, the phrasing “Provided the place of VR…” is awkward wording).

References

Petri, K., Feuerstein, K., Folster, S., Bariszlovich, F., & Witte, K. (2020). Effects of Age, Gender, Familiarity with the Content, and Exposure Time on Cybersickness in Immersive Head-mounted Display Based Virtual Reality. American Journal of Biomedical Sciences, 12(2),107-121.

Reviewer #2: Thank you for the opportunity to read this article. This paper touches on an important topic and is well-written. Some minor comments for the author's consideration:

1) Is there a sample size calculation?

2) Would this lead to another distraction if participants were asked to immediately describe their state of discomfort?

3) How to judge whether the immersion will stop when the score reaches 16/20?

4) It is recommended to add a limitation and conclusion section.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Mar 11;20(3):e0319661. doi: 10.1371/journal.pone.0319661.r003

Author response to Decision Letter 1


2 Dec 2024

REVIEWERS' COMMENTS

Reviewer #1:

This is an interesting study investigating the effects of odor imagery on cybersickness. Using a within-subject design, the authors examined whether individuals (N = 28) demonstrate changes in cybersickness across two timepoints (with 6 months apart), having watched images of pleasant fruit (different for each subject) at T2. The results indicate that cybersickness was significantly lower during the 2nd visit, where odor imagery was displayed during the VR task (as opposed to a black square during the VR task for the 1st visit). The study is concise, largely well-written, and focuses on an interesting topic. There are some caveats, however, detailed below.

The authors should provide a clear justification for the use of within- rather than a between-subjects design. The reason for this is that it is not possible to deduce that the reduction in cybersickness was due to odor imagery, as there should have been a comparison or a control group not receiving the OI.

Author’s response:

We thank Reviewer #1 for this insight. The choice of a within-subjects design was motivated by our main question, which was the improvement of well-being in VR, by using individually-selected visual cues.

We understand the Reviewer’s concern on the absence of a control group. However, it is well known that susceptibility to cybersickness is extremely variable between individuals, and depends on many factors (some of which are difficult if not impossible to control). For this reason, pairing a control group based on a prediction of their sensitivity to our virtual environment would have been extremely complex. The risk would be to obtain controls which respond differently to our virtual environment, questioning the relevance of a between-groups comparison. Consequently (and for ethical considerations which are addressed in the Reviewer’s next point, see below) we focused on a within-subject design.

However, we do agree with the Reviewer about the fact that other factors may have contributed to the decrease in cybersickness which we observed in our study. These factors (i.e., the presence of a visual anchorage, and other mechanisms of attentional reallocation) are addressed in our discussion section. Our future work, which already wields interesting preliminary results presented in our discussion, will focus on these questions and provide more insight regarding the role of odor imagery specifically, relatively to other potential confounding factors.

Reviewer’s comment:

In addition, a priori power analysis should have been conducted and reported, but if this was not done, then sensitivity analysis would be useful considering the small sample. Having run a quick power analysis using similar parameters, the current sample size appears to be too small (my results yielded a minimum sample of 36). The authors should expand on this.

Author’s response:

The sample size for this study was determined based on the nature of our study rather than a power analysis. The clinical trial which the present study was part of (CANOE NCT05308433), includes an fMRI session in which all participants took part. Because this project was exploratory, ethical requirements were to determine the sample based on the main goal of the clinical trial, which was in fMRI. This limited us to a sample size of 30 participants.

We understand the Reviewer’s concerns regarding the sample size, which we share. This is why our statistical analyses focused on a within-subjects design, in an attempt to maximize our statistical power. In addition, effect sizes are specified in the manuscript.

Reviewer’s comment:

The authors should justify the use of their VR immersion scenario. It sounds like the scenario was designed to induce cybersickness (in addition, the authors should provide more details about this, rather than just a reference), and that participants were asked to sit still and not tilt their head too much. Nevertheless, cybersickness often appears in more innocuous scenarios (e.g., walking around, peering down, etc.). How does the study scenario compare to cybersickness induced by more typical usage (e.g., during video game play)? This should be clarified.

Author’s response:

We chose to use the virtual environment described in Fantin et al. (2023), since it has been validated in experimental settings and offers interesting features to control cybersickness to a certain extent. The following parameters are described in the original publication, and were chosen following several pre-tests:

- Waves were set at 0.7m of amplitude at two frequencies of 0.3Hz and 0.5Hz.

- Simulated head movements were set at:

o Pitch and yaw: 4deg amplitude at a frequency of 0.1Hz.

o Roll: 7deg amplitude, at 0.4Hz.

We understand that readers may want more information in our article, which is why we have added some justification to our choice of stimulation (page 6, lines 127-132) : “This virtual environment has been designed and previously used (…) original publication”

For the precise settings of frequency and amplitude of waves and simulated head movements, we encourage readers to refer to the original publication (Fantin et al., 2023).

Moreover, we are fairly certain that this scenario can compare to cybersickness in other types of virtual environment. Cybersickness is usually seen as the result of a cognitive-sensory conflict, which was the case in our study even though participants were stationary and passive. The use of this “passive” scenario allowed for participants to experiment the virtual environment similarly and concentrate on odor imagery with no confound related to their expertise in gaming. In our discussion section, we do however discuss the possible difficulties that users could encounter if they were asked to perform odor imagery while simultaneously playing a game in a virtual environment. This limit related to cognitive load has been acknowledged and should be addressed in future studies.

Reviewer’s comment:

Methods: there are details lacking about psychometric properties of the scales used, the type of standardization method used for numerical data, and how outlier removal was conducted (and why it was removed rather than using other methods, considering the small sample size).

Author’s response:

The scales for descriptive statistics (MSSQ, VIMSSQ, ITQ) and for our formal analyses (SSQ, IPQ) are validated tools. Our work referenced each of the original publications which describe their properties and how scores are calculated.

The following information has been added accordingly with the Reviewer’s suggestions:

- Numerical data were centered reduced (page 10, line 209)

- Removal of one influential observation was performed after plotting standardized residuals against leverage (page 10, lines 210-211)

Outlier removal was performed rather than other methods since it offered the best compromise between the respect of statistical assumptions, and interpretability in the context of our questioning. This is especially true since it only resulted in the exclusion of 1 participant, which we considered acceptable for this exploratory analysis.

We thank Reviewer #1 for pointing out these omissions and we hope that this answers their concerns.

Reviewer’s comment:

A major limitation regarding the study conclusions is the effect of familiarity using the VR the 2nd time around. Although the participants were asked about their motion sickness susceptibility and prior engagement with technology, having experienced the VR scenario once does create familiarity with the environment the next time around, which could impact on cybersickness (see e.g., Petri et al., 2020).

Author’s response:

We thank Reviewer #1 for raising this point. If our understanding of Petri et al.’s study is correct, “familiarity” in this case familiarity with content of the depicted task (in this case experts in karate vs non-experts), rather than being familiar with a specific virtual environment.

We are aware that there have been some studies on the potential impact of repeated exposure to VR, namely cybersickness abatement by repeated exposure (CARE). However, these methodologies rely on multiple VR exposures with little rest time (sessions are usually organized on successive days) and use complementary manipulation of visual stimulation, such as peripheral FoV reduction. Outside of these specific studies, most reports of adaptation to VR take place over a much longer time scale.

In our study, participants only performed two experimental sessions which were purposely set 6 months apart to limit any potential effect of the first session on the second. Moreover, adding to odor imagery task during the second session changed visual and cognitive constraints applied on participants, further reducing any effect of familiarity to the task and the environment. For these reasons, we believe that the mitigation of cybersickness we observe is not due to any form of familiarity.

Reviewer’s comment:

On a minor note, I suggest the paper is proof-read by an English speaker, as there are minor grammatical errors throughout (e.g., Introduction, 1st paragraph, the phrasing “Provided the place of VR…” is awkward wording).

The article has been proof-read and minor corrections have been applied throughout the manuscript. We thank the Reviewer for their insight.

*************************************

Reviewer #2:

Thank you for the opportunity to read this article. This paper touches on an important topic and is well-written. Some minor comments for the author's consideration:

Reviewer’s comment:

Is there a sample size calculation?

Author’s response:

As stated in the responses to Reviewer #1, sample size for this study was not determined based on a power analysis. The clinical trial which the present study was part of (CANOE NCT05308433), includes an fMRI session in which all participants took part. Because this project was exploratory, ethical requirements were to determine the sample based on the main goal of the clinical trial, which was in fMRI. This limited us to a sample size of 30 participants.

Reviewer’s comment:

Would this lead to another distraction if participants were asked to immediately describe their state of discomfort?

Author’s response:

If we understand correctly, Reviewer #2 suggests that we ask participants to describe their discomfort qualitatively rather than using a number during the virtual immersions.

While it is an interesting suggestion, it does in our opinion have some methodological issues. Mainly, it would be difficult to control the amount of detail with which each participant would describe this discomfort. On the contrary, verbalizing numbers allows for more homogenized speech time. It is also possible that verbally describing one’s state of discomfort may increase one’s focus toward these symptoms, and as a consequence increase them.

Therefore, we decided to use the Fast Motion Sickness Scale in line with previous works, using it only as a control in order to discontinue virtual immersions when needed.

Reviewer’s comment:

How to judge whether the immersion will stop when the score reaches 16/20?

Author’s response:

Most previous works on cybersickness or other forms of transient discomfort have used scales in order to regularly control participant’s state. It is also an important ethical consideration that participants do not experience an unnecessary amount of discomfort.

Generally, these studies discontinue stimulation when participants reach a sufficient level of discomfort, corresponding to values around 75% of the maximum : 16/20 for the FMS (Fantin et al., 2023; Keshavarz B & Hecht H, 2011), or 4/6 for scales with lower resolution such as the Sickness Rating scale (Cian et al., 2011).

The threshold used in our study was also intended to be close to that of the original authors of the FMS : “… FMS scores were verbally requested and noted by the experimenter once a minute. The very last score was reported at the moment of video fade-out or just before the experiment was prematurely aborted. The latter could occur at the participant’s request or if the experimenter considered the MS score to be indicative of impending frank sickness. When a score of 15 had been reached, the experimenter deliberately asked the participant if he or she wanted to abort the experiment.”(Keshavarz & Hecht, 2011)

In any case, the virtual immersions were discontinued whenever participants expressed the will to stop, as specified in our methods section.

References :

Cian, C., Ohlmann, T., Ceyte, H., Gresty, M. A., & Golding, J. F. (2011). Off vertical axis rotation motion sickness and field dependence. Aviation, Space, and Environmental Medicine, 82(10), 959-963.

Fantin, L., Ceyte, G., Maïni, E., Hossu, G., & Ceyte, H. (2023). Do individual constraints induce flexibility of visual field dependence following a virtual immersion? Effects of perceptive style and cybersickness. Virtual Reality, 27(2), 917-928.

Keshavarz, B., & Hecht, H. (2011). Validating an efficient method to quantify motion sickness. Human factors, 53(4), 415-426.

Reviewer’s comment:

It is recommended to add a limitation and conclusion section.

Author’s response:

We thank Reviewer #2 for this observation. We have added a conclusion section containing the key messages of our study.

The limits of our study do appear throughout the discussion section rather than in a separate section, which was an intentional choice on our part. We believe it is relevant to use them to nuance the main results that we present and discuss. We hope that this choice will still satisfy the Reviewer’s demands.

Attachment

Submitted filename: Response to reviewers.docx

pone.0319661.s002.docx (33.2KB, docx)

Decision Letter 1

Jeyasakthy Saniasiaya

6 Feb 2025

Is it all in your head? Reducing virtual reality induced cybersickness by pleasant odor imagery

PONE-D-24-38671R1

Dear Dr. Ceyte,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jeyasakthy Saniasiaya, MD, MMed ORLHNS, FEBORLHNS

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Revisions has been adequately addressed

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Thank you for your revision! The author has responded to all my comments.

I have no other comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #2: Yes:  Cho Lee Wong

**********

Acceptance letter

Jeyasakthy Saniasiaya

PONE-D-24-38671R1

PLOS ONE

Dear Dr. Ceyte,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jeyasakthy Saniasiaya

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0319661.s002.docx (33.2KB, docx)

    Data Availability Statement

    All data used for the descriptive statistics or formal analyses are publicly available at https://doi.org/10.6084/m9.figshare.26927116.v1


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES